Ads
related to: prostate cancer recurrence- nmCRPC Treatment Option
31% Risk of Death Decrease
Visit The Patient Site.
- Dosing & Administration
View Recommended Dosage & Learn
About Drug Interactions Here.
- Clinical Information
Read About A Double-Blind, Placebo-
Controlled, Randomized Study.
- mHSPC Treatment Option
32% Risk of Death Decrease
Visit The Patient Site.
- Downloadable Resources
Resources For Physicians & Patients
Available On The Site To Download.
- Patient Profiles
Explore Patient Profiles To Assess
A Treatment Option.
- nmCRPC Treatment Option
Search results
Study supports watch-and-wait approach to slow-growing prostate cancer
UPI· 4 days agoAlmost half or prostate cancer patients in a recent study never needed to resort to active...
Does Diet Affect Progression Risk After Prostate Cancer?
Medscape· 4 days agoAfter diagnosis and treatment of prostate cancer, men who predominantly consumed plant-based diets...
Plant-Based Diets Lower The Risk Of Prostate Cancer Progressing By 47%
Forbes· 6 days agoA recent JAMA Network Open study of men who were diagnosed with prostate cancer found that people...
More Evidence Backs Active Surveillance for Low-Risk Prostate Cancer
MedPage Today· 5 days agoAt 10 years, 43% of more than 2,000 patients had biopsy grade reclassification, and 49% had...
Targeting 'monster cancer cells' could reduce recurrence rates after cancer therapy
Medical Xpress· 6 days agoIn a recent article in the Journal of Biological Chemistry, an MUSC Hollings Cancer Center research team led by Christina Voelkel-Johnson, Ph.D., reports that it has identified ...
Breast cancer: New blood test can predict return, researchers say
BBC News· 1 day agoAn "ultra-sensitive" new blood test can predict if breast cancer will return years before the...
YOUR HEALTH: Postage stamp-sized treatment for brain tumors
WAFB Baton Rouge· 10 hours agoMore than 200,000 people in the U.S. are diagnosed with an aggressive brain tumor each year. Now,...
Gamechanging blood test predicts breast cancer relapse up to three years early
Daily Express· 2 days agoAn “ultra-sensitive” blood test can predict which breast cancer survivors will relapse years before...
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
Zacks via Yahoo Finance· 6 days agoCandel (CADL) surges 431% in the year-to-date period, driven by positive developmental and...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 16 hours agoFor the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a ...
